Mayo Clinic study on damage from puberty blockers included ‘transgender’ two-year-old

(LifeSiteNews) — A new study from the Mayo Clinic adds further evidence that puberty blockers are not reversible and can in fact create long-lasting consequences.

But it also shows how gender ideology continues to infect children at a younger and younger age – according to the study, the Mayo Clinic saw a two-year-old who it claimed had gender dysphoria.

“The average age at the time of gender transition and fertility preservation (FP) surgery is 8.1 (age range = 2—15; std deviation = 4.6) and 12.5-years old (age range = 10—16; std deviation = 1.8), respectively,” the authors of the preprint study wrote. “The average age of [puberty blocker] initiation is 12.1-years old (age range = 10—16.4; std deviation = 1.83).”

The study included 16 gender dysphoric males who took puberty blockers. “Two out of 9 PB-treated patients exhibited abnormalities: one had bilateral abnormal testicles with a lack of complete tunica albuginea, while another had a right testis that was not easily palpable,” the study found.

The researchers were able to compare the cells from these males with others who did not use puberty blockers to create a control group.

The Mayo Clinic team found “mild-to-severe sex gland atrophy” in the cells of boys who had taken puberty blockers. A 12-year-old boy in the study had “59 % of sex glands fully atrophied with appearance of microlithiasis.”

“Testicular microlithiasis…is a condition in which small clusters of calcium form in the testicles,” according to the Mayo Clinic.

A 14-year-old boy also showed “stunted” sperm production.

Independent journalist Christina Buttons, who regularly covers the harms of transgender drugs and surgeries, wrote in her analysis:

The study observed that over 90% of the cells responsible for sperm production in this patient were stunted at an early developmental stage, unable to progress further. Additionally, it found “pathologically” higher and lower levels of two types of support cells (Sertoli cells) necessary for healthy sperm development. These findings suggest that puberty blockers can disrupt the normal maturation process of cells critical for sperm production. https://www.lifesitenews.com/news/mayo-clinic-study-puberty-blockers-transgender/?utm_source=featured-news&utm_campaign=usa